9

Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer.

Jørgensen T, Yogesan K, Tveter KJ, Skjorten F, Danielsen HE.

Cytometry. 1996

SPCG-2

Abstract

8

Up-Regulation of the Oligosaccharide Sialyl Lewis-x: A New Prognostic Parameter in Metastatic Prostate Cancer

Jørgensen T, Berner A, Kaalhus O, Tveter KJ Danielsen HE, Bryne M

Cancer Res. 1995

SPCG-2

Abstract

7

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer

Jørgensen T, Yogesan K, Skjørten F, Berner A, Tveter KJ, Danielsen HE

Br J Cancer. 1995

SPCG-2

Abstract

6

Extent of disease based on initial bone scan: important prognostic predictor for patients with metastatic prostatic cancer. Experience from the Scandinavian Prostatic Cancer Group Study No. 2

Jørgensen T, Müller C, Kaalhus O, Danielsen HE, Tveter KJ

Eur Urol. 1995

SPCG-2

Abstract

5

Localized prostate cancer – A Scandinavian View

Iversen P, Adolfsson, Johansson JE, Torp-Pedersen S.

Monographs in Urology 1994

Abstract

4

Total androgen suppression: Experience from the Scandinavian Prostate Cancer Group Study No. 2

Jørgensen T, Tveter KJ, Jørgensen LH, SPCG-2 group

Eur Urol. 1993

SPCG-2

Abstract

3

DNA as a prognostic marker in advanced high-grade prostatic cancer. A preliminary report. SPCG-1 study.

Hedlund PO, Esposti P, Falkmer U, Jacobsen H.

Acta Oncol. 1991

SPCG-1

Abstract

2

Carcinoma of the Prostate, views and recommendations.

Iversen P.

Scand J Urol Nephrol 1991

Abstract

1

Acid phosphatases and other tumour markers in the management of prostate cancer.

Hörder M, Rasmussen F

Scand J Clin Lab Invest Suppl. 1985

Abstract